| Title |
Cancer and stroke: commonly encountered by clinicians, but little evidence to guide clinical approach
|
|---|---|
| Published in |
Therapeutic Advances in Neurological Disorders, June 2022
|
| DOI | 10.1177/17562864221106362 |
| Pubmed ID | |
| Authors |
Malin Woock, Nicolas Martinez-Majander, David J. Seiffge, Henriette Aurora Selvik, Annika Nordanstig, Petra Redfors, Erik Lindgren, Mayte Sanchez van Kammen, Alexandros Rentzos, Jonathan M. Coutinho, Karen Doyle, Halvor Naess, Jukka Putaala, Katarina Jood, Turgut Tatlisumak |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 50% |
| Finland | 1 | 25% |
| United Kingdom | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 2 | 50% |
| Members of the public | 1 | 25% |
| Science communicators (journalists, bloggers, editors) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 33 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 4 | 12% |
| Student > Master | 4 | 12% |
| Student > Ph. D. Student | 3 | 9% |
| Student > Doctoral Student | 1 | 3% |
| Other | 1 | 3% |
| Other | 3 | 9% |
| Unknown | 17 | 52% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 7 | 21% |
| Neuroscience | 2 | 6% |
| Nursing and Health Professions | 1 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
| Business, Management and Accounting | 1 | 3% |
| Other | 1 | 3% |
| Unknown | 20 | 61% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 July 2022.
All research outputs
#15,326,205
of 25,728,855 outputs
Outputs from Therapeutic Advances in Neurological Disorders
#376
of 660 outputs
Outputs of similar age
#198,852
of 443,339 outputs
Outputs of similar age from Therapeutic Advances in Neurological Disorders
#12
of 22 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 660 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.1. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 443,339 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.